Lorillard Tobacco Company Statement Regarding FDA Panel Public Meeting

Source from:  Lorillard, Inc. 03/31/2010

Lorillard Tobacco Company today issued the following statement regarding the Food and Drug Administration's Tobacco Products Scientific Advisory Committee (TPSAC) which is holding its first public meeting this week.　This statement can be attributed to Dr. Bill True, Senior Vice President. "The FDA's scientific advisory committee will be looking at many aspects of regulation but one major challenge will be for committee members to remain focused on an objective analysis of the science surrounding menthol. "Menthol, obviously, has been used for decades in food, drink, cosmetics and other products.　And the science is clear and compelling that there is no differing health risk between menthol and non-menthol products. "With respect to public health, using the best methods available to science, it is clear a menthol cigarette is just another cigarette and should be treated no differently." About Lorillard, Inc. Lorillard, Inc. (NYSE:LO - News) is the third largest manufacturer of cigarettes in the United States. Founded in 1760, Lorillard is the oldest continuously operating tobacco company in the U.S. Newport®, Lorillard's flagship menthol-flavored premium cigarette brand, is the top selling menthol and second largest selling cigarette in the U.S. In addition to Newport, the Lorillard product line has five additional brand families marketed under the Kent®, True®, Maverick®, Old Gold® and Max® brand names. These six brands include 41 different product offerings which vary in price, taste, flavor, length and packaging. Lorillard maintains its headquarters and manufactures all of its products in Greensboro, North Carolina. For more information, visit the Company's web site at http://www.lorillard.com/. Enditem